Juergen Foell

2.7k total citations
28 papers, 793 citations indexed

About

Juergen Foell is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Juergen Foell has authored 28 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Genetics and 6 papers in Hematology. Recurrent topics in Juergen Foell's work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (7 papers). Juergen Foell is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (7 papers). Juergen Foell collaborates with scholars based in Germany, United States and Austria. Juergen Foell's co-authors include Robert S. Mittler, Megan McCausland, Michael K. Hoffmann, Xiao‐Jie Yan, Shawn P. O’Neil, Carolyn Suwyn, Praveen Chander, Michael Haber, Nicholas Chiorazzi and Selim Corbacioglu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Juergen Foell

25 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juergen Foell Germany 15 544 153 97 83 71 28 793
Tariq El‐Shanawany United Kingdom 17 467 0.9× 249 1.6× 91 0.9× 41 0.5× 72 1.0× 29 890
Kamruz Darabi United States 8 447 0.8× 218 1.4× 71 0.7× 148 1.8× 47 0.7× 13 749
Gary S. Wood United States 17 382 0.7× 228 1.5× 89 0.9× 57 0.7× 25 0.4× 18 1.0k
Masanao Asano United States 9 963 1.8× 83 0.5× 147 1.5× 71 0.9× 28 0.4× 14 1.2k
Jürgen Enczmann Germany 20 454 0.8× 130 0.8× 162 1.7× 92 1.1× 77 1.1× 50 1.0k
Fengqi An United States 6 734 1.3× 64 0.4× 102 1.1× 42 0.5× 69 1.0× 9 895
W.‐K. Hofmann Germany 15 304 0.6× 110 0.7× 248 2.6× 203 2.4× 58 0.8× 22 905
Michelle R. Tourigny United States 8 634 1.2× 141 0.9× 195 2.0× 36 0.4× 102 1.4× 8 904
Ursula Holzer Germany 17 366 0.7× 125 0.8× 183 1.9× 62 0.7× 20 0.3× 45 729
Elisa Montaldo Italy 19 1.4k 2.5× 201 1.3× 104 1.1× 36 0.4× 34 0.5× 28 1.6k

Countries citing papers authored by Juergen Foell

Since Specialization
Citations

This map shows the geographic impact of Juergen Foell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Foell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Foell more than expected).

Fields of papers citing papers by Juergen Foell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Foell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Foell. The network helps show where Juergen Foell may publish in the future.

Co-authorship network of co-authors of Juergen Foell

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Foell. A scholar is included among the top collaborators of Juergen Foell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Foell. Juergen Foell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Corbacioglu, Selim, Holger N. Lode, Meinolf Suttorp, et al.. (2023). Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial.. Journal of Clinical Oncology. 41(16_suppl). 10001–10001. 1 indexed citations
3.
Foell, Juergen, et al.. (2020). Alternative donor. Hematology/Oncology and Stem Cell Therapy. 13(2). 98–105. 29 indexed citations
4.
Foell, Juergen, Johannes H. Schulte, Anja Troeger, et al.. (2019). Haploidentical CD3 or α/β T-cell depleted HSCT in advanced stage sickle cell disease. Bone Marrow Transplantation. 54(11). 1859–1867. 29 indexed citations
5.
6.
Sauer, Harald, et al.. (2017). Bone marrow aspirations in oncological patients: experience from an in-house standard in paediatrics. Wiener Medizinische Wochenschrift. 169(3-4). 82–86. 2 indexed citations
7.
Hennig, Christian, et al.. (2009). Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B‐cell immunodeficiencies with Rituximab. British Journal of Haematology. 148(3). 445–448. 7 indexed citations
8.
Foell, Juergen, et al.. (2008). Loss of detectability of Charcot–Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide. Journal of Immunological Methods. 339(1). 99–103. 18 indexed citations
9.
Polte, Tobias, et al.. (2007). CD137 ligand prevents the development of T‐helper type 2 cell‐mediated allergic asthma by interferon‐γ‐producing CD8+ T cells. Clinical & Experimental Allergy. 37(9). 1374–1385. 16 indexed citations
10.
Zhang, Benyue, Charles H. Maris, Juergen Foell, et al.. (2007). Immune suppression or enhancement by CD137 T cell costimulation during acute viral infection is time dependent. Journal of Clinical Investigation. 117(10). 3029–3041. 48 indexed citations
11.
Schlaf, Gerald, et al.. (2007). A novel HLA‐B*35 (B*3570) allele of a Caucasian family differing with one amino acid mismatch from HLA‐B*3503 allele in exon 4. Tissue Antigens. 70(1). 72–73. 1 indexed citations
12.
Foell, Juergen, Matthias Fischer, Michael Seibold, et al.. (2006). Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatric Blood & Cancer. 49(6). 858–861. 20 indexed citations
13.
Foell, Juergen & Robert S. Mittler. (2006). Costimulatory molecules as immunotherapeutic targets in systemic lupus erythematosus. Springer Seminars in Immunopathology. 28(2). 153–162. 6 indexed citations
14.
Stiefel, Martina, Theodore F. Reiss, Martin S. Staege, et al.. (2005). Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma. Pediatric Blood & Cancer. 49(2). 203–207. 11 indexed citations
15.
16.
17.
Mittler, Robert S., et al.. (2004). Anti-CD137 Antibodies in the Treatment of Autoimmune Disease and Cancer. Immunologic Research. 29(1-3). 197–208. 53 indexed citations
18.
Foell, Juergen, Shawn P. O’Neil, Megan McCausland, et al.. (2003). CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice. Journal of Clinical Investigation. 111(10). 1505–1518. 133 indexed citations
19.
Foell, Juergen, Shawn P. O’Neil, Megan McCausland, et al.. (2003). CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice. Journal of Clinical Investigation. 111(10). 1505–1518. 145 indexed citations
20.
Foell, Juergen, Megan McCausland, Xiao‐Jie Yan, et al.. (2003). CD137‐Mediated T Cell Co‐Stimulation Terminates Existing Autoimmune Disease in SLE‐Prone NZB/NZW F1 Mice. Annals of the New York Academy of Sciences. 987(1). 230–235. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tariq El‐Shanawany Breakdown of academic impact, for papers by Kamruz Darabi Breakdown of academic impact, for papers by Gary S. Wood Breakdown of academic impact, for papers by Masanao Asano Breakdown of academic impact, for papers by Jürgen Enczmann Breakdown of academic impact, for papers by Fengqi An Breakdown of academic impact, for papers by W.‐K. Hofmann Breakdown of academic impact, for papers by Michelle R. Tourigny Breakdown of academic impact, for papers by Ursula Holzer Breakdown of academic impact, for papers by Elisa Montaldo
Rankless by CCL
2026